Evidence map›Paper›PMID 35181796›Full record

ArticleDer Internist2022

[Experiences with digital care of patients with chronic and acute lung diseases during the SARS-CoV-2 pandemic].

Marcel Braun, Olaf Schmidt, Thomas Schultz, Holger Woehrle, Martina Große Sundrup, Christoph Schöbel

Open access · hybridAbstract read
In one paragraph

Article in Der Internist, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marcel BraunUniversitätsmedizin Essen, Ruhrlandklinik - Westdeutsches Lungenzentrum, Klinik für Pneumologie, Lehrstuhl für Schlaf- und Telemedizin, Universität Duisburg-Essen, Essen, Deutschland.
Olaf SchmidtKPPK Studienzentrum Koblenz/Pneumologische Gemeinschaftspraxis Koblenz, Koblenz, Deutschland.
Thomas SchultzPneumologenLichterfelde Berlin, Berlin, Deutschland.
Holger WoehrleLungenzentrum Ulm, Ulm, Deutschland.
Martina Große SundrupUniversitätsmedizin Essen, Ruhrlandklinik - Westdeutsches Lungenzentrum, Klinik für Pneumologie, Lehrstuhl für Schlaf- und Telemedizin, Universität Duisburg-Essen, Essen, Deutschland.
Christoph SchöbelUniversitätsmedizin Essen, Ruhrlandklinik - Westdeutsches Lungenzentrum, Klinik für Pneumologie, Lehrstuhl für Schlaf- und Telemedizin, Universität Duisburg-Essen, Essen, Deutschland. christoph.schoebel@rlk.uk-essen.de.
University of Duisburg-Essen · DERuhrlandklinik · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundManagement of patients with respiratory disorders, such as asthma or chronic obstructive pulmonary disease (COPD), became challenging during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic due to infection prevention measures. To maintain care, a remote monitoring program was initiated, comprising a smartphone app and a Bluetooth spirometry device.

objectiveTo assess patient- and physician-related experience with remote monitoring. MATERIAL AND

methodsStructured questionnaires were developed to rate experiences from the patient or physician perspective on six-level Likert scales. Interactions between patients and physicians via the digital platform and overall utilization was analyzed.

resultsA total of 745 patients with asthma, COPD, post-coronavirus disease 2019 (COVID-19) and other respiratory diseases were enrolled from 31 centers in Germany. Mean follow-up was 49.4 ± 12.6 weeks. Each participant submitted on average 289 measurements. Patient-reported experience with the remote monitoring program was positive, with the highest satisfaction reported for "Experience with home measurement" (1.4 ± 0.5; 99% positive), followed by "Communication/interaction" (1.8 ± 0.9; 83% positive) and "Overall satisfaction with program" (1.8 ± 0.8; 87% positive). In all, 70% reported subjective quality of life improvements related to participation in the program. Physician satisfaction with the program was also high with a mean rating of 2.2 ± 1.2. DISCUSSION: App-based remote monitoring was successfully implemented in routine care during the SARS-CoV‑2 pandemic and demonstrated potential for improvements in care. Patient-relevant experience was positive in all dimensions and remote monitoring was well accepted. Physicians who participated in the program also expressed positive experiences, as demonstrated by a high level of interaction with the platform and positive evaluations of effects from the program.

Indexed as

COVID-19Lung DiseasesHumansPandemicsQuality of LifeSARS-CoV-2AsthmaPatient-reported experiencePulmonary disease, chronic obstructiveRemote monitoringSpirometry

Identifiers

PMID35181796
PMCPMC8856116
OpenAlexW4212763107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.